News Room

Below, you'll find a list of all our latest press releases. Clicking any of the titles below will open up the full text of the press release in Adobe PDF format.


May 17, 2016

TriFoil Imaging installs Russias first 3D Optical Imager

In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia's first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of Experimental Animal Genetic Resources the Federal Research Center Institute of Cytology and Genetics the Siberian Branch of the Russian Academy of Sciences.

Prof. Evgeny Zavyalov, head of SPF Vivarium, "There are similar systems but only this advanced system provides true 3D whole body optical imaging. The InSyTe FLECT/CT system will be used for experimental oncology. The optical imaging will allow for more detailed studies in the field of cardiology, neurology and other areas of science."


November 09, 2015

New Article on LabOnline about the InSyTe Series!

Trifoil InSyTe FLECT-CT tomographic optical imaging system

The InSyTe from Trifoil provides true 360° tomographic optical preclinical imaging. This enables researchers to perform in vivo imaging of small animals in a compact, powerful benchtop system. The capabilities match that of nuclear imaging modalities such as PET and SPECT.

Read the full article by clicking on the link above.


June 02, 2015

Bar Ilan University Medical School installs Triumph PET/CT System

The research facility at Bar Ilan University (BIU), Safed, Israel has installed a Triumph II PET/CT. This multi-modality imaging system is the first small animal imaging system to be installed at Bar ILan Faculty of Medicine in the Galilee.  The system was installed under the operation of Prof. Izhak Haviv for cancer research.

"Through our distributor in Israel, Lavi MedTech we are honored to have been selected to provide BIU their first multi-modality small animal imaging system," said TriFoil Director of Sales Sean Pitts. "We look forward to working closely with BIU and Lavi to help facilitate any research or imaging they require in the future."

Read the full press release by clicking the link above!


April 27, 2015

Latvian Institute of Organic Synthesis installs InSyTe FLECT/CT preclinical imaging system

TriFoil Imaging is excited to announce that the research facility at Latvian Institute of Organic Synthesis (IOS), Latvia, has installed an InSyTe FLECT/CT. This system was sold through TriFoil Imaging's distributor in the CIS Countries and Scandinavia, GenMedica-Baltic. The system was installed under the operation of the IOS Laboratory of Pharmaceutical Pharmacology, Head Prof. Maija Dambrova, for drug discovery research.

Prof. Dambrova states: "With InSyTe FLECT/CT 360º system we will be able to study true anatomical displacement of small animals and accurately measure fluorophore concentrations throughout the region of interest. We will monitor the progression of atherosclerosis in aorta, ischemia-reperfusion or traumatic injury in the brain, permeability of vasculature and inflammation. In addition, we can evaluate the efficacy of the treatment when studying novel compounds. InSyTe FLECT/CT system could be used also by other laboratories/groups of IOS that are or will be interested in studying angiogenesis, apoptosis, cancer or infectious diseases."


April 06, 2015

PUCRS - Brazil | Publishes The First Research Article using Preclinical PET Data

The first ever research article using the Triumph LabPET4 or any preclinical PET system in Brazil!

Antidepressant Effects of Ketamine Are Not Related to 18F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats

EXCERPT FROM ABSTRACT:  "Major depressive disorder (MDD) is an important health problem that is often associated to stress.  One of the main brain regions related to MDD is the ventral tegmental area (VTA), a dopaminergic center, part of the reward and motivation circuitry. Recent studies show that changes to VTA dopaminergic neurons are associated with depression and treatment. Ketamine has recently shown a fast, potent antidepressant effect in acute, sub-anesthetic doses. Thus, our aims were to elucidate if ketamine would be able to revert depression-like behaviors induced by a chronic unpredictable stress (CUS) protocol and if it could cause alterations to metabolism and tyrosine hydroxylase (TH)-immunoreactivity in VTA..."

Click on the link above to read the full article


April 27, 2015

TriFoil Imaging is proud to announce the appointment of BioVitrum as its exclusive distributor in all regions of Russia and Kazakhstan

In collaboration with its Partner, GenMedica-Baltic, and in response to the growing demand for its digital preclinical nuclear and optical imagers, TriFoil Imaging is proud to announce the appointment of BioVitrum as its exclusive distributor in all regions of Russia and Kazakhstan. TriFoil Imaging is excited to work with BioVitrum, a fast-growing and well-established company in medical and laboratory equipment, renowned for promoting and supporting innovative products and technologies in Russia: http://www.biovitrum.ru/en/company/history.


February 13, 2015

AXT adds TriFoil imaging products to their preclinical imaging portfolio


AXT's recently appointed Business Development Manager for in vivo Products Steve Hunter said, "The addition of TriFoil Imaging products to our range gives us a variety of imaging solutions second to none. Their innovative products are world-leading and we look forward to growing their user-base across Australia in the near future"


August 14, 2014

TriFoil Imaging installs Triumph II SPECT/CT at LSU Baton Rouge

"We are honored to have been selected again by LSU to provide our Triumph SPECT/CT platform. At TriFoil Imaging, our goal is to provide cutting edge performance with even better service and support and repeat business is the best indicator that we are doing that successfully," said TriFoil Director of Sales Sean Pitts. "We look forward to working with LSU and Dr. Mathis' group for years to come."


December 31, 2013

Integrated PET/MRI in preclinical studies: State of the art

Take a look at this article on the integration of PET and MRI for preclinical imaging.


June 19, 2014

BioOptics World: News article on the InSyTe Series

Click on this link to read the news article on our new InSyTe Series:  The multi-modality imaging bench top series with 360° CT.  

Tabletop system offers fluorescence CT for in vivo small-animal imaging.

Don't forget to check out the article on our new imaging system in the BioOptics World September issue featuring 3D optical imagining.


June 10, 2014

TriFoil Imaging launches InSyTe, first-ever bench top multi-modality imaging series with in-line CT

The First-Ever bench top animal multi-modality imaging series with in-line (full 360°) CT. Customers have the option of ordering their InSyTe system in either FLECT™ (360° Optical Imaging), PET (APD Technology) or MMP-SPECT™ with or without CT, as well as a standalone CT.

Contact us for InSyTe on this cutting edge system that is smaller and easy to use without having to sacrifice imaging quality and performance.

MarketWired.com-TriFoil-Imaging-Launches-InSyTe


September 03, 2013

TriFoil Imaging Acquires Bioscan

TriFoil Imaging today announced the signing of a definitive agreement to acquire certain assets of privately-held Bioscan, Inc., a leading supplier of multimodal preclinical molecular imaging technologies. TriFoil and Bioscan will combine their robust in-vivo molecular capabilities and technical expertise to provide universities, pharmaceutical companies and contract research organizations with the highest quality imaging technologies.


September 05, 2013

TriFoil bids for Bioscan

TriFoil Imaging has inked a definitive agreement to acquire fellow preclinical imaging technology developer Bioscan.


June 10, 2013

Johns Hopkins, TriFoil unveil SPECT/MR device at SNMMI

Preclinical hybrid SPECT/MR imaging system unveiled at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting by researchers from John Hopkins University.


May 08, 2013

Capital Resource Partners Purchases Gamma Medica’s Pre-Clinical Business to Form New Entity, Trifoil Imaging

With the same proven senior management team at the helm, Trifoil will focus on driving product innovation in the in-vivo molecular imaging market with its one-of-a-kind TriumphTM tri-modality and eXplore CT-120 products.

Aunt Minnie article:  HERE


January 28, 2013

Bioscan Completes Delivery of First Commercial BioFLECT™ Systems

Washington, DC, USA - January 28, 2013 – Bioscan is excited to announce the delivery of the first commercial BioFLECT instruments.

January 13, 2012

Bioscan R&D Center Dijon France

Bioscan's new French subsidiary will implement research and development activities contributing to the "IMAPPI" project, designing and developing a prototype PET/MRI solution that can foster innovation around early detection of tumors.


January 13, 2012

Bioscan R&D Center Dijon France (French Version)

La société Bioscan, Inc. choisit Dijon pour implanter son centre de R&D européen qui contribuera au projet collaboratif « IMAPPI » afin de concevoir et développer un prototype IRM-TEP innovant favorisant la détection très en amont des tumeurs.


January 02, 2012

BioFLECT selected as one of the Top 10 Innovations of 2011 by The Scientist magazine

Bioscan's new 360-degree tomographic optical imager, BioFLECT, was awarded 2nd place in The Scientist's Top 10 Innovations of 2011. BioFLECT uses a rotating ring of high-sensitivity photodetectors with a wide dynamic range, which permits whole body, deep tissue imaging to generate a full 3D scan of fluorescent markers in live animals.


March 23, 2011

Bioscan's SPECT/CT in-vivo preclinical imaging system highlighted on French Television

Bioscan's SPECT/CT in-vivo preclinical imaging system was featured in a recent news segment on nanoparticles and cell therapeutrics. The broadcast highlighted the work of Dr. Claire Bilottey, Pr. Marc Janier & Pr. Frederic Berard, who are affiliated with CHU LYon/Universite Claude Bernard Lyon 1. Watch the video


March 23, 2011

Bioscan's Fabrice Chaumard discusses the Intergrated Magnetic resonance And Positron emission Tomography in Preclinical Imaging project (IMAPPI)

Bioscan's European Director, Fabrice Chaumard, recently sat down to discuss the IMAPPI project, which will culuminate in the commercilization and production of an interegrated PET/MRI system for use in in-vivo preclinical imaging applications. Watch the video.


March 03, 2011

Bioscan receives major grant from French government for development of an integrated preclinical PET/MRI system

In the framework of its "Equipements d'excellence" initiative, the French Commissariat Général à l'Investissement has granted €7.3 million for the Integrated Magnetic resonance And Positron emission tomography in Preclinical Imaging project (IMAPPI)


June 06, 2010

Bioscan’s NanoSPECT/CT enables a landmark study on the in-vivo use of nanotubes for organ-specific therapeutics and diagnostics

WASHINGTON, DC – June 6, 2010. Bioscan, Inc. (Washington, DC) today announced the publication of the first in-vivo application of functionalized sealed carbon nanotubes filled with a radionuclide without prompting cargo release. The stability and biocompatibility of the capsule together with the radioactive payload allows in-vivo imaging of disease models and delivery of a high-density radiodose.